Biobot Analytics is a technology company that deploys wastewater monitoring equipment and analytical tools to provide novel public health insights at the community level.
Biobot Analytics develops cutting-edge technology to transform sewers into public health observatories.
Biobot Analytics was founded in 2017 by Mariana Matus and Newsha Ghaeli. The company is headquartered in Somerville, Massachusetts.
Biobot Analytics' mission is to transform wastewater infrastructure into public health observatories.
Biobot Analytics' wastewater monitoring technology analyzes urine and stool samples to create a health database that is independent from hospital reporting systems, free from societal biases affecting who can and can’t seek care, and most importantly, rapidly adaptable to new and emerging public health threats.
Biobot Analytics' first product is to measure opioids and other drug metabolites in sewage to estimate consumption in cities. With this data, those working on harm reduction can assess the scope of the epidemic, allocate resources, and gauge the effectiveness of programming over time.
Biobot Analytics is backed by The Engine, Y Combinator, Ekistic Ventures, AmFam Institute Impact Fund and others. The company raised $4.2M in a Seed round on Apr 21, 2020. This brings Biobot Analytics' total funding to $6.7M to date.